Article
Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis.
The Journal of rheumatology
Document Type
Conference Proceeding
Publication Date
10-1-2020
URL with Digital Object Identifier
https://doi.org/10.3899/jrheum.200480
Disciplines
Abstract
The Canadian Inflammatory Myopathy Study (CIMS) is a multicenter prospective cohort recruiting in 8 centers across Canada. One of the aims of CIMS is to conduct and participate in clinical trials in autoimmune inflammatory myopathies (AIM). Conducting clinical trials in rare diseases such as AIM presents challenges. During this symposium, experts in the field presented different solutions to successfully conduct clinical trials in AIM, including the importance of collaboration and careful trial design, as well as training and mentoring of young investigators.
Creative Commons License
Creative Commons Attribution-Noncommercial 4.0
Citation Information
Valérie Leclair, Océane Landon-Cardinal, Rohit Aggarwal, Nick Bansback, et al.. "Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis." The Journal of rheumatology Vol. 47 Iss. 10 (2020) p. 1584 - 1586 Available at: http://works.bepress.com/craig-campbell/28/